Literature DB >> 32138433

The role of prolactin in the pathogenesis of autoimmune disease.

Istvan Berczi1.   

Abstract

Prolactin has emerged in recent years as a major regulator of both the maturation and the function of lymphocytes. Prolactin abnormalities, which include elevated serum levels, decreased bioactivity, abnormal circadian rhythm, and exaggerated secretion after stimulation by TRH, are associated with various autoimmune conditions in humans. Some animal experiments and observations in humans indicate that proiactin has an important role in the pathogenesis of autoimmune disease. There are several mechanisms through which prolactin could promote the development of autoimmunity. It is concluded that prolactin abnormalities alone are not likely to cause autoimmunity, but rather additional regulatory defects are perhaps also required for disease to develop.

Entities:  

Keywords:  Endocrine Pathology Volume; Hyperprolactinemia; Natural Killer Activity; Prolactin; Prolactin Receptor

Year:  1993        PMID: 32138433     DOI: 10.1007/BF02915460

Source DB:  PubMed          Journal:  Endocr Pathol        ISSN: 1046-3976            Impact factor:   3.943


  127 in total

1.  Autoimmune diseases: the failure of self tolerance.

Authors:  A A Sinha; M T Lopez; H O McDevitt
Journal:  Science       Date:  1990-06-15       Impact factor: 47.728

2.  Peptide epitope induced apoptosis of human cytotoxic T lymphocytes. Implications for peripheral T cell deletion and peptide vaccination.

Authors:  A Suhrbier; S R Burrows; A Fernan; M F Lavin; G D Baxter; D J Moss
Journal:  J Immunol       Date:  1993-03-15       Impact factor: 5.422

3.  Double-blind pilot trial of oral tolerization with myelin antigens in multiple sclerosis.

Authors:  H L Weiner; G A Mackin; M Matsui; E J Orav; S J Khoury; D M Dawson; D A Hafler
Journal:  Science       Date:  1993-02-26       Impact factor: 47.728

4.  Prolactin receptor triggering. Evidence for rapid tyrosine kinase activation.

Authors:  H Rui; J Y Djeu; G A Evans; P A Kelly; W L Farrar
Journal:  J Biol Chem       Date:  1992-11-25       Impact factor: 5.157

5.  Serum beta-endorphin in rheumatic disorders.

Authors:  C W Denko; J Aponte; P Gabriel; M Petricevic
Journal:  J Rheumatol       Date:  1982 Nov-Dec       Impact factor: 4.666

6.  Placental lactogen is a haemopoietic hormone.

Authors:  I Berczi; E Nagy
Journal:  Br J Haematol       Date:  1991-11       Impact factor: 6.998

7.  Effect of prolactin on the diurnal changes in immune parameters and plasma corticosterone in white leghorn chickens.

Authors:  K Skwarlo-Sonta; J Sotowska-Brochocka; D Rosolowska-Huszcz; E Pawlowska-Wojewódka; A Gajewska; D Stepień; K Kochman
Journal:  Acta Endocrinol (Copenh)       Date:  1987-10

8.  Hypochlorhydria and hypergastrinaemia in rheumatoid arthritis.

Authors:  T J de Witte; P J Geerdink; C B Lamers; A M Boerbooms; J K van der Korst
Journal:  Ann Rheum Dis       Date:  1979-02       Impact factor: 19.103

9.  Correlation study between prolactin and androgens in male patients with systemic lupus erythematosus.

Authors:  C Lavalle; E Loyo; R Paniagua; J A Bermudez; J Herrera; A Graef; D Gonzalez-Barcena; A Fraga
Journal:  J Rheumatol       Date:  1987-04       Impact factor: 4.666

10.  Regulation of humoral immunity in rats by pituitary hormones.

Authors:  I Berczi; E Nagy; K Kovacs; E Horvath
Journal:  Acta Endocrinol (Copenh)       Date:  1981-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.